Fifteen-minute consultation: The child with short stature

Nadia Amin1, Talat Mushtaq1, Sabah Alvi1

  • 1Department of Paediatric Endocrinology, Leeds Children's Hospital, Leeds, UK.

Insights

Short stature in children causes distress but is often not pathological. This guide outlines evaluating short stature, identifying causes, and growth hormone treatment indications.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Short stature is a common concern for families, causing significant psychosocial distress.
  • While often benign, identifying underlying pathological causes is crucial for timely intervention.
  • Accurate diagnosis is essential for appropriate management and treatment of pediatric short stature.

Purpose of the Study:

  • To present a systematic approach for evaluating children with short stature.
  • To outline differential diagnoses for pediatric short stature.
  • To detail first-line investigations and growth hormone treatment indications.

Main Methods:

  • Systematic review of diagnostic approaches for short stature.
  • Analysis of differential diagnoses based on clinical presentation and initial tests.
  • Review of evidence for growth hormone therapy efficacy and indications.

Main Results:

  • Short stature evaluation requires a structured approach including history, physical examination, and biochemical/radiological tests.
  • Common causes include familial short stature, constitutional delay of growth and puberty, and various endocrine/genetic conditions.
  • Growth hormone therapy is indicated for specific conditions like growth hormone deficiency and Turner syndrome.

Conclusions:

  • A systematic evaluation is key to differentiating pathological from non-pathological short stature.
  • Early identification of treatable conditions ensures optimal growth outcomes.
  • Growth hormone treatment offers a viable therapeutic option for selected pediatric patients with short stature.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
23.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391